Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Brain Behav Immun. 2012 Aug 3;26(7):1122–1127. doi: 10.1016/j.bbi.2012.07.014

Table 2.

Comparison of KIR gene frequencies for subjects with autism from the UT/OR and AGRE populations against the CEPH control population. The two autistic populations were compared separately and then combined when compared to the control population.

CEPH
Controls
UT/OR(n=70) AGRE(n=88) Combined UT/OR & AGRE(n=158)


KIR UT/OR OR 95% CI p-value AGRE OR 95% CI p-value Both OR 95% CI p-value
2DS2 97 37 0.89 (0.51, 1.56) 0.682 53 1.20 (0.71, 2.03) 0.489 90 1.05 (0.68, 1.62) 0.824
2DS3 46 24 1.47 (0.81, 2.69) 0.203 30 1.46 (0.84, 2.55) 0.180 54 1.47 (0.92, 2.35) 0.110
2DS5 53 33 2.04 (1.15, 3.61) 0.014 35 1.51 (0.88, 2.58) 0.133 68 1.72 (1.10, 2.71) 0.018
3DS1 65 41 2.41 (1.37, 4.26) 0.002 42 1.56 (0.93, 2.62) 0.093 83 1.89 (1.22, 2.93) 0.004
2DS1 67 45 2.93 (1.64, 5.22) 0.0003
0.025*
50 2.14 (1.27, 3.61) 0.004 95 2.45 (1.58, 3.82) 0.00007
0.006*
2DS4 160 68 3.40 (0.76, 15.3) 0.109 86 8.60 (1.11, 66.6) 0.038 154 5.13 (1.45, 18.1) 0.010
2DL2 96 38 1.06 (0.60, 1.86) 0.851 50 1.10 (0.65, 1.84) 0.726 88 1.08 (0.70, 1.67) 0.733
2DL3 162 66 1.90 (0.53, 6.88) 0.325 78 0.67 (0.29, 1.59) 0.366 144 0.96 (0.43, 2.11) 0.913
2DL1 172 68 0.79 (0.14, 4.46) 0.789 85 0.66 (0.14, 3.03) 0.590 153 0.71 (0.19, 2.71) 0.617
3DL1 174 64 0.12 (0.02, 0.63) 0.011 84 0.24 (0.04, 1.36) 0.105 148 0.17 (0.04, 0.79) 0.024
2DL5A 63 39 2.16 (1.22, 3.80) 0.008 41 1.50 (0.89, 2.53) 0.130 80 1.75 (1.30, 2.74) 0.012

Bold type p-values significant at the p≤0.05 level. Bonferroni allelic corrected p-values significant at the p≤0.05 are listed below in Bold type*.